Evidence map›Paper›PMID 32710228›Full record

ArticleTissue engineering and regenerative medicine2020

Effect of Integrin Binding Peptide on Vascularization of Scaffold-Free Microtissue Spheroids.

Ziyşan Buse Yaralı, Günnur Onak, Ozan Karaman

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering and regenerative medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Vascularized Tissue Organoids.Bioengineering (Basel, Switzerland) · 2023
    Review
  5. Methods for vascularization and perfusion of tissue organoids.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Review
  6. Advanced Multi-Dimensional Cellular Models as Emerging Reality to ReproduceInternational journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ziyşan Buse YaralıTissue Engineering and Regenerative Medicine Laboratory, Department of Biomedical Engineering, Faculty of Engineering and Architecture, Rm 148, İzmir Katip Çelebi University, 35620, Izmir, Turkey.
Günnur OnakTissue Engineering and Regenerative Medicine Laboratory, Department of Biomedical Engineering, Faculty of Engineering and Architecture, Rm 148, İzmir Katip Çelebi University, 35620, Izmir, Turkey.
Ozan KaramanTissue Engineering and Regenerative Medicine Laboratory, Department of Biomedical Engineering, Faculty of Engineering and Architecture, Rm 148, İzmir Katip Çelebi University, 35620, Izmir, Turkey. ozan.karaman@ikc.edu.tr.ORCID 0000-0002-4175-4402
Izmir Kâtip Çelebi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThree-dimensional (3D) biomimetic models via various approaches can be used by therapeutic applications of tissue engineering. Creating an optimal vascular microenvironment in 3D model that mimics the extracellular matrix (ECM) and providing an adequate blood supply for the survival of cell transplants are major challenge that need to be overcome in tissue regeneration. However, currently available scaffolds-depended approaches fail to mimic essential functions of natural ECM. Scaffold-free microtissues (SFMs) can successfully overcome some of the major challenges caused by scaffold biomaterials such as low cell viability and high cost.

methodsHerein, we investigated the effect of soluble integrin binding peptide of arginine-glycine-aspartic acid (RGD) on vascularization of SFM spheroids of human umbilical vein endothelial cells. In vitro-fabricated microtissue spheroids were constructed and cultivated in 0 mM, 1 mM, 2 mM, and 4 mM of RGD peptide. The dimensions and viability of SFMs were measured.

resultsMaximum dimension and cell viability observed in 2 mM RGD containing SFM. Vascular gene expression of 2 mM RGD containing SFM were higher than other groups, while 4 mM RGD containing SFM expressed minimum vascularization related genes. Immunofluorescent staining results indicating that platelet/endothelial cell adhesion molecule and vascular endothelial growth factor protein expression of 2 mM RGD containing SFM was higher compared to other groups.

conclusionCollectively, these findings demonstrate that SFM spheroids can be successfully vascularized in determined concentration of RGD peptide containing media. Also, soluble RGD incorporated SFMs can be used as an optimal environment for successful prevascularization strategies.

Indexed as

Tissue EngineeringVascular Endothelial Growth Factor AHumansHuman Umbilical Vein Endothelial CellsIntegrinsPeptidesIntegrinsPeptidesVascular Endothelial Growth Factor AIntegrin binding peptideScaffold-free microtissueTissue engineeringVascularization

Identifiers

PMID32710228
PMCPMC7524969
OpenAlexW3044430109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.